Skip to content
WeighLab

Nova vs Fitstry

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

Nova

Provider comparison

Readers who want the membership inside the quoted price rather than added to it, and who want a daily sublingual option beside the injection.

Semaglutide / month
$152/moAll-in, a starting price that rises with dose (medication, shipping and the $50/mo membership; daily sublingual from $127)
Tirzepatide / month
$167/moAll-in, a starting price that rises with dose (same bundle; daily sublingual from $127)
Index 75/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Nova pricing Read review

Fitstry

Provider comparison

Shoppers who want month-to-month compounded GLP-1 pricing with coaching, labs and a named physician setting the protocols.

Semaglutide / month
$249Every 4 weeks (month-to-month, compounded; daily tablet $279)
Tirzepatide / month
$339Every 4 weeks (month-to-month, compounded)
Index 74/100 · Grade CChecked October 2026

Compounded drugs are not FDA-approved. Understand the medication options.

Check Fitstry pricing Read review

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

Nova has the higher Cost-Efficiency Index: 75/100 versus 74/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

Nova

Fitstry

Semaglutide / month
Nova: $152/moAll-in, a starting price that rises with dose (medication, shipping and the $50/mo membership; daily sublingual from $127)
Fitstry: $249Every 4 weeks (month-to-month, compounded; daily tablet $279)
Tirzepatide / month
Nova: $167/moAll-in, a starting price that rises with dose (same bundle; daily sublingual from $127)
Fitstry: $339Every 4 weeks (month-to-month, compounded)
Semaglutide / year (modeled)
Nova: $1,824
Fitstry: $3,23713 charges
Tirzepatide / year (modeled)
Nova: $2,004
Fitstry: $4,40713 charges
State availability
Nova: 49 states
Fitstry: 49 states
Oral / sublingual option listed
Nova: Yes
Fitstry: Yes
Brand-name access listed
Nova: Not confirmed
Fitstry: Not confirmed
Provider facts checked
Nova: October 2026
Fitstry: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

Nova

Readers who want the membership inside the quoted price rather than added to it, and who want a daily sublingual option beside the injection.

Reasons to consider it

  • Quotes one all-in figure that already contains the $50 monthly membership, the medication and refrigerated shipping, so the membership is not a surprise at checkout
  • Names a medical director and a nurse practitioner with credentials, training and residency detail
  • Prices a daily sublingual route for both molecules alongside the weekly injections

What to weigh up

  • Every figure is a "From" price that depends on the dose your provider prescribes, and no maintenance-dose price is published
  • No compounding pharmacy and no medical group is named
  • "You're only charged if prescribed" sits against a refund policy making membership and consultation fees non-refundable once the clinical review is done, even when a provider declines

Compounded drugs are not FDA-approved. Understand the medication options.

Check Nova pricing Read the full Nova review

Fitstry

Shoppers who want month-to-month compounded GLP-1 pricing with coaching, labs and a named physician setting the protocols.

Reasons to consider it

  • Publishes month-to-month prices: compounded semaglutide $249, tirzepatide $339 and a daily tablet $279, cancel any time
  • No program fee for now, and the first month is refunded in full if a clinician doesn't approve you
  • Clinical protocols set by a named board-certified physician, Dr. Sergio Naccarato, MD

What to weigh up

  • Bills every four weeks, so a year is 13 charges, not 12
  • The lower 'starting at' prices on its cards aren't tied to a stated plan length
  • The program fee is waived only for a limited time, and its amount isn't published

Compounded drugs are not FDA-approved. Understand the medication options.

Check Fitstry pricing Read the full Fitstry review

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

NovaFitstry
Normalized Cost/Month
Nova:
70/100
Fitstry:
56/100
Price Transparency
Nova:
78/100
Fitstry:
86/100
Nationwide Access
Nova:
78/100
Fitstry:
78/100
Formulation Options
Nova:
77/100
Fitstry:
77/100
Clinical Oversight
Nova:
73/100
Fitstry:
81/100
Contract Flexibility
Nova:
73/100
Fitstry:
77/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Alternatives to NovaAlternatives to Fitstry
More provider matchups
CoreAge Rx vs NovaCoreAge Rx vs Fitstry
Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.